1. Drug Repurposing in Oncology: Current Evidence and Future Direction
   Zhenzhan Zhang et al, 2021, Current Medicinal Chemistry CrossRef
2. Comparison of PLA-Based Micelles and Microspheres as Carriers of Epothilone B and Rapamycin. The Effect of Delivery System and Polymer Composition on Drug Release and Cytotoxicity against MDA-MB-231 Breast Cancer Cells
   Katarzyna Jelonek et al, 2021, Pharmaceutics CrossRef
3. Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
   Qingrong Li et al, 2021, OncoTargets and Therapy CrossRef
4. Dihydroartemisinin Reduces Irradiation-Induced Mitophagy and Radioresistance in Lung Cancer A549 Cells via CIRBP Inhibition
   Shunlong Wu et al, 2022, Life CrossRef
5. Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
   Ran Yu et al, 2021, Frontiers in Oncology CrossRef
6. The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies?
   Kamil Seyrek et al, 2022, Biochemical Journal CrossRef
7. The prognostic value of GSK3ß, eEF2K, and Atg7 expressions in triple-negative breast cancers: a clinicopathological study
   OlaA Harb et al, 2020, Egyptian Journal of Pathology CrossRef
8. Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment
   Rebecca H. Horton et al, 2020, Current Cancer Drug Targets CrossRef